INOVIO PHARMACEUTICALS, INC
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
License fee and milestone revenue
License fee and milestone revenue from affiliated entity
Grant and miscellaneous revenue
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income, net
Interest income, net
(Loss)/Gain from investment in affiliated entity
Gain on sale of assets
Net loss attributable to non-controlling interest
Net loss attributable to Inovio Pharmaceuticals, Inc.
Loss per common share — basic and diluted:
Net loss per share attributable to Inovio Pharmaceuticals, Inc. stockholders
Weighted average number of common shares outstanding — basic and diluted
Subscribe to our Free Newsletters!
Nocturnal polyuria refers to increased urine output during night, without an associated increase in ...
Nootropics are drugs or substances which improve cognition that are being increasingly used ...
Pterygium or Surfer's eye is described as a proliferative disorder of the ocular surface possibly ...View All